Drug Shortage Report for TUSSIONEX
| Report ID | 42990 |
| Drug Identification Number | 01916971 |
| Brand name | TUSSIONEX |
| Common or Proper name | Tussionex Suspension |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROCODONE PHENYLTOLOXAMINE |
| Strength(s) | 5MG 10MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 500ml |
| ATC code | R05DA |
| ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2018-05-01 |
| Actual start date | 2018-05-01 |
| Estimated end date | 2018-08-15 |
| Actual end date | 2018-07-25 |
| Shortage status | Resolved |
| Updated date | 2018-07-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-03-15 | English | Compare |
| v2 | 2018-03-15 | French | Compare |
| v3 | 2018-05-02 | English | Compare |
| v4 | 2018-06-12 | English | Compare |
| v5 | 2018-06-12 | French | Compare |
| v6 | 2018-07-26 | English | Compare |
| v7 | 2018-07-26 | French | Compare |
Showing 1 to 7 of 7